Navigation Links
Synthetic catalyst mimics nature's 'hydrogen economy'
Date:5/18/2009

CHAMPAIGN, Ill. By creating a model of the active site found in a naturally occurring enzyme, chemists at the University of Illinois have described a catalyst that acts like nature's most pervasive hydrogen processor.

The researchers describe their work in a paper accepted for publication in the Journal of the American Chemical Society, and posted on the journal's Web site.

Scientists have long been puzzled by nature's ability to use cheap and plentiful building blocks iron, nickel and sulfur to achieve the catalytic performance seen in rare and expensive metals. In particular, two enzymes iron-iron hydrogenase and nickel-iron hydrogenase function as hydrogen processors, much like platinum.

"Nature relies on a very elaborate architecture to support its own 'hydrogen economy,' " said Thomas B. Rauchfuss, a professor of chemistry and corresponding author of the paper. "We cracked that design by generating mock-ups of the catalytic site to include the substrate hydrogen atom."

The researchers' model of the nickel-iron complex is the first to include a bridging hydride ligand, an essential component of the catalyst.

"By better understanding the mechanism in the nickel-iron hydrogenase active site, we are learning how to develop new kinds of synthetic catalysts that may be useful in other applications," said graduate student Bryan E. Barton, lead author of the paper.

"The study of hydrogenases offers plenty of potential glamour such as the hydrogen economy, green energy and bio-fuel cells but the lasting breakthroughs result from manipulable mechanistic models like ours," said graduate student and co-author Matthew Whaley. "By building a model that contains a hydride ligand, we have proven that the behavior of these natural catalysts can be understood and optimized."


'/>"/>

Contact: James E. Kloeppel
kloeppel@illinois.edu
University of Illinois at Urbana-Champaign
Source:Eurekalert

Page: 1

Related biology news :

1. Synthetic chemical offers solution for crops facing drought
2. Using combinatorial libraries to engineer genetic circuits advances synthetic biology
3. Orientation of antenna protein in photosynthetic bacteria described
4. Synthetic biology can help extend anti-malaria drug effectiveness
5. Milestone achieved toward production of malaria treatment using synthetic biology and fermentation
6. Synthetic biology key in the 21st century
7. Synthetic biology: Is ethics a showstopper?
8. Synthetic virus supports a bat origin for SARS
9. UNC scientists teach enzyme to make synthetic heparin in more varieties
10. Biosynthetics production with detours
11. Synthetic Biology: Coming Up Fast!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special ... Kephart of Identity Strategy Partners, LLP, today releases ... "Executive Order: Protecting the Nation From Foreign Terrorist Entry ... "As President Trump,s ,Travel Ban, Executive Order gains more ... the travel ban, it is important that our national ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... -- Fluxion Biosciences announced today that Genetracer Biotech of ... as a Certified Service Provider for Fluxion,s IsoFlux CTC ... in Genetracer Biotech,s novel liquid biopsy workflows for detection ... plans to move to other cancers as additional assays ... to isolate, recover, and analyze CTCs (circulating tumor cells) ...
(Date:2/25/2017)... Garden City, New York (PRWEB) , ... February ... ... announced their partnership with Verified Clinical Trials in an ongoing effort ... the areas of treatment, advocacy, and pharmaceutical research with emphasis on consumers and ...
(Date:2/24/2017)... 24, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... participate in its previously announced rights offering of ... of common stock and Series C Convertible Preferred ... warrants. As previously announced, the ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: